Common Contracts
14 similar Incentive Stock Option Agreement contracts by Immunogen Inc, Interleukin Genetics Inc, Alphatec Holdings, Inc., others
INCENTIVE STOCK OPTION AGREEMENT SHARES OF COMMON STOCK, $.0001 PAR VALUE PER SHAREIncentive Stock Option Agreement • March 31st, 2017 • Madrigal Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
INCENTIVE STOCK OPTION AGREEMENT INTERLEUKIN GENETICS, INC.Incentive Stock Option Agreement • March 20th, 2014 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • Delaware
AGREEMENT made as of the [_____] day of [_______] 20[___], between Interleukin Genetics, Inc. (the “Company”), a Delaware corporation having a principal place of business in Waltham, Massachusetts, and [_________________], an employee of the Company (the “Employee”).
INCENTIVE STOCK OPTION AGREEMENT ALPHATEC HOLDINGS, INC.Incentive Stock Option Agreement • March 5th, 2013 • Alphatec Holdings, Inc. • Surgical & medical instruments & apparatus • Delaware
AGREEMENT made as of ___________________, between Alphatec Holdings, Inc. (the “Company”), a Delaware corporation, and ______________________, an employee of the Company (the “Employee”).
INCENTIVE STOCK OPTION AGREEMENT INTERLEUKIN GENETICS, INC.Incentive Stock Option Agreement • March 25th, 2010 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • Delaware
AGREEMENT made as of the _____ day of _________ 200__, between Interleukin Genetics, Inc. (the “Company”), a Delaware corporation having a principal place of business in _Waltham__, _Massachusetts__, and ___________ of _______________________________, _________, an employee of the Company (the “Employee”).
MYRIAD PHARMACEUTICALS, INC. INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • June 8th, 2009 • Myriad Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Agreement sets forth the terms of the incentive stock option (“ISO”) grant made by Myriad Pharmaceuticals, Inc. (the “Company”), a Delaware corporation having a principal place of business in Salt Lake City, Utah, to the individual specified in the Notice of Grant of Stock Option and Option Agreement (the “Employee”).
MYRIAD GENETICS, INC. INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • November 1st, 2007 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Delaware
This Agreement sets forth the terms of the incentive stock option (“ISO”) grant made by Myriad Genetics, Inc. (the “Company”), a Delaware corporation having a principal place of business in Salt Lake City, Utah, to the individual specified in the Notice of Grant of Stock Option and Option Agreement (the “Employee”).
INCENTIVE STOCK OPTION AGREEMENT ASIANADA, INC.Incentive Stock Option Agreement • October 15th, 2007 • Asianada, Inc. • Metal mining • Delaware
AGREEMENT made as of the ___ day of _________ 200_, between Asianada, Inc. (the “Company”), a Delaware corporation and ____________, an employee of the Company (the “Employee”).
INCENTIVE STOCK OPTION AGREEMENT CAMPUSU, INC.Incentive Stock Option Agreement • June 26th, 2007 • CampusU • Virginia
AGREEMENT made as of the ___ day of _______ 200_, between CampusU, Inc. (the “Company”), a Delaware corporation, and ____________ of ____________, an employee of the Company (the “Employee”).
INCENTIVE STOCK OPTION AGREEMENT RESPONSE GENETICS, INC.Incentive Stock Option Agreement • May 3rd, 2007 • Response Genetics Inc • In vitro & in vivo diagnostic substances • Delaware
AGREEMENT made as of the ___ day of _______ 200_, between Response Genetics, Inc. (the “Company”), a Delaware corporation and ____________, an employee of the Company (the “Employee”).
INCENTIVE STOCK OPTION AGREEMENT JAMBA, INC.Incentive Stock Option Agreement • December 5th, 2006 • Jamba, Inc. • Blank checks • Delaware
This Incentive Stock Option Agreement (this “Agreement”) made as of the date set forth in the Notice of Grant of Stock Option to which this Agreement is attached (the “Grant Notice”) is between Jamba, Inc. (the “Company”), a Delaware corporation, and the individual named in the Grant Notice (the “Employee”).
IMMUNOGEN, INC. INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • November 15th, 2006 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
AGREEMENT made as of the day of 200 , between ImmunoGen, Inc. (the “Company”), a Massachusetts corporation, and , an employee of the Company (the “Employee”).
IMMUNOGEN, INC. INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • November 15th, 2006 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
AGREEMENT made as of the day of 200 , between ImmunoGen, Inc. (the “Company”), a Massachusetts corporation, and , an employee of the Company (the “Employee”).
INCENTIVE STOCK OPTION AGREEMENT COLEY PHARMACEUTICAL GROUP, INC.Incentive Stock Option Agreement • November 10th, 2005 • Coley Pharmaceutical Group, Inc. • Pharmaceutical preparations • Delaware
AGREEMENT made as of the “Effective Date” set forth in the Notice of Grant of Stock Options and Option Agreement attached as Exhibit A to this Agreement, between Coley Pharmaceutical Group, Inc., a Delaware corporation having a principal place of business at 93 Worcester Street, Suite 101, Wellesley, Massachusetts 02481 (the “Company”), and an employee of the Company listed and identified in Exhibit A (the “Employee”).
INCENTIVE STOCK OPTION AGREEMENT ORCHID BIOSCIENCES, INC.Incentive Stock Option Agreement • June 14th, 2005 • Orchid Biosciences Inc • In vitro & in vivo diagnostic substances • Delaware
AGREEMENT made as of the day of , 200 , between Orchid BioSciences, Inc. (the “Company”), a Delaware corporation having a principal place of business in Princeton, New Jersey, and , an employee of the Company (the “Employee”).
